Microalbuminuria and its relation to cardiovascular disease and risk factors. A population-based study of 1254 hypertensive individuals

[1]  J. M. Macleod,et al.  Albumin excretion and vascular deaths in NIDDM , 1995, Diabetologia.

[2]  H. Parving,et al.  Albuminuria and Poor Glycemic Control Predict Mortality in NIDDM , 1995, Diabetes.

[3]  M. Nannipieri,et al.  Increased Transcapillary Escape Rate of Albumin in Microalbuminuric Type II Diabetic Patients , 1995, Diabetes Care.

[4]  J. Yudkin,et al.  Associations of urinary albumin excretion rate with vascular disease in europid nondiabetic subjects. , 1994, Journal of diabetes and its complications.

[5]  T. Risler,et al.  Microalbuminuria in essential hypertension. Reduction by different antihypertensive drugs. , 1993, Hypertension.

[6]  A. Fitzgerald,et al.  Prospective Study of Microalbuminuria as Predictor of Mortality in NIDDM , 1992, Diabetes.

[7]  C. Mogensen,et al.  Microalbuminuria as predictor of increased mortality in elderly people. , 1990, BMJ.

[8]  V. Moiseyev,et al.  CARDIOVASCULAR AND RENAL EFFECTS OF RAMIPRIL , 1989, The Lancet.

[9]  J. Bauer,et al.  Effect of nifedipine on renal function in patients with essential hypertension. , 1988, Hypertension.

[10]  M. Marre,et al.  Laser immunonephelometry for routine quantification of urinary albumin excretion. , 1987, Clinical chemistry.

[11]  Epidemiology of chest pain and angina pectoris, with special reference to treatment needs. , 1984, Acta medica Scandinavica. Supplementum.

[12]  H. Blackburn,et al.  Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.